Newsletter | September 29, 2025

09.29.25 -- Application Of Process Analytical Technology In ADC Bioconjugation Processes

Application Of Process Analytical Technology (PAT) In The Antibody-Drug Conjugate (ADC) Bioconjugation Process

Integrating Process Analytical Technology (PAT) into validated GMP environments demands more than just technical know-how. Explore the critical role PAT plays in ADC manufacturing, highlighting the challenges and considerations that come with embedding it into GMP workflows.

 

Leveraging Process Analytical Technology For Developing Novel Conjugates

This webinar on Process Analytical Technology (PAT) provides valuable insights into its benefits for accelerating process development and its impact on the development and manufacture of novel conjugates. Leveraging an advanced Antibody-Drug Conjugate (ADC) platform and integrating PAT into development workflows enhance process efficiency and ensure the delivery of high-quality products from the start.

 

PAT Implementation For ADC & Bioconjugation Processes: Applications And Case Studies

Process Analytical Technology (PAT) plays a vital role in enhancing process control and deepening process understanding. In this webinar gain valuable insights into PAT implementation for ADC and bioconjugation processes, and how drug developers and manufacturers can access real-time insights into their process parameters and product attributes, enabling proactive adjustments and optimization.

 

SOLUTIONS

Comprehensive ADC And Bioconjugation Services For Targeted Therapies

Uncover a trusted CDMO partner with more than 15 years of industry-leading experience in conjugation and purpose-built manufacturing facilities that offer end-to-end services to help bring your ADCs and bioconjugates into the clinic and to commercialization.

• Request Information

 

 

ADC AND BIOCONJUGATION CDMO SERVICES

ADC And Bioconjugation CDMO Services

Antibody-drug conjugates (ADCs) have ignited a new era of targeted cancer therapies but there are several obstacles and complexities to overcome to bring these therapies to market. To solve the challenges and ensure success of your ADC project, you can rely on an industry-leading CDMO partner with 15+ years experience and focused expertise to meet your ADC development and manufacturing needs, from pre-clinical to commercial. Learn more.